ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

ClinicalTrials.gov ID: NCT02592798

Public ClinicalTrials.gov record NCT02592798. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 10:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Randomized, Placebo-Controlled, Double-Blind, Parallel Arms, Pilot Study to Evaluate the Efficacy and Safety of Intravenous Abatacept in Treatment Resistant Nephrotic Syndrome (Focal Segmental Glomerulosclerosis/ Minimal Change Disease)

Study identification

NCT ID
NCT02592798
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
36 participants

Conditions and interventions

Interventions

  • Abatacept Drug
  • D5W Other
  • Normal Saline Other

Drug · Other

Eligibility (public fields only)

Age range
6 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 8, 2016
Primary completion
Jan 27, 2020
Completion
Jan 27, 2020
Last update posted
Mar 4, 2021

2016 – 2020

United States locations

U.S. sites
27
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
The University Of Alabama At Birmingham Birmingham Alabama 35233
University of Alabama-Birmingham-Parent Account Birmingham Alabama 35294
Los Angeles Biomedical Research Institute Torrance California 90502
University Of Colorado Denver Aurora Colorado 80045
Children's National Health System Washington D.C. District of Columbia 20010
University Of Miami Miller School Of Medicine Miami Florida 33136
Nemours Childrens Hospital Orlando Florida 32827
Emory University Atlanta Georgia 30322-1015
Loyola University Medical Center Maywood Illinois 60153
NIH Clinical Center - NIDDK Bethesda Maryland 20892
Boston Childrens Hospital Boston Massachusetts 02115
Brigham And Women'S Hosp Inc. Boston Massachusetts 02115
University of Michigan Ann Arbor Michigan 48109
Mayo Clinic Rochester Minnesota 55905
Childrens Mercy Hospital Kansas City Missouri 64108
New York University Langone Medical Center New York New York 10016
Columbia University Medical Center (Cumc) New York New York 10032
Levine Children's Hospital Charlotte North Carolina 28203
Duke University Durham North Carolina 27701
Cincinnati Children'S Hospital Medical Center Cincinnati Ohio 45229-3039
The Metro Health System Cleveland Ohio 44109
Cleveland Clinic Cleveland Ohio 44195
The Ohio State University Wexner Medical Center Columbus Ohio 43210
University Of Pennsylvania Philadelphia Pennsylvania 19104
Local Institution Pittsburgh Pennsylvania 15224
Renal Disease Research Institute Dallas Texas 75235
University Of Texas Southwestern Medical Center Dallas Texas 75390

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02592798, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 4, 2021 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02592798 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →